Researchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four cancers. The enzyme, N4BP2, breaks apart DNA trapped in tiny cellular ...
CEO Abizer Gaslightwala discusses the Company’s recent announcement around its ADC pipeline expansion and IP strategy ...
Morning Overview on MSN
Deadly brain cancer with no cure may finally have a kill switch
Glioblastoma is the diagnosis that neuro-oncologists dread and patients fear, a fast-growing brain cancer that resists surgery, radiation, and chemotherapy and almost always returns. For decades, the ...
PM EST TAMPA, Fla. and LONDON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology ...
In 2023, Krainer published a paper in which he showed SRSF1’s involvement in PDAC. The most common form of pancreatic cancer, PDAC is also the most life- threatening. By increasing SRSF1 into a system ...
A new deep-learning AI model may help scientists better decipher the plot of the genetic instruction book and learn how typos alter the story. AlphaGenome, created by Google DeepMind, is the latest in ...
Sometimes, in genetics, two wrongs do make a right. A research team has recently shown that two harmful genetic variants, when occurring together in a gene, can restore function—proving a decades-old ...
In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific Northwest Research Institute (PNRI) have overturned a long-held belief in ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms these tags actively silence genes, ...
A Silicon Valley startup backed by OpenAI’s Sam Altman and Coinbase’s Brian Armstrong is pursuing research that some fear could lead to the birth of a genetically engineered baby — a step that’s ...
San Antonio Spurs phenom Victor Wembanyama is such a unique talent that he can't be compared to just one all-time great. Kevin Garnett and Kendrick Perkins have gone on record to say that his game is ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results